Gilteritinib For Patients With FLT3+ AML

Editor

6 years ago

Edward Copelan, MD Chair, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute Discusses Gilteritinib For Patients With FLT3+ AML At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com